Associated Papers
Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing.
Lang GT et al.
Nature Communications, 2020
33173047 (PubMed )
Supplement: 41467_2020_19342_MOESM7_ESM.xlsx › PGI_fudan_NC_clnical.oc
Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy.
Caswell-Jin JL et al.
Nature Communications, 2019
30737380 (PubMed )
Supplement: 41467_2019_8593_MOESM6_ESM.xlsx › SuppData3B
Select a paper to view details